Skip to main content

Table 2 Content of the questionnaires of the SALT Osteoporosis Study

From: Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older

Theme Questionnaire
Fractures Q1, Q2, Q3
Examination for osteoporosis Q1, Q2, Q3
Hip fractures of close family Q1, Q2, Q3
Falls in last 12 months Q1, Q2, Q3
Fear of falling Q1, Q2, Q3
Mobility and use of walking aid Q1, Q2, Q3
Height and weight Q1, Q2, Q3
Living situation Q1, Q2, Q3
Education level Q1
Ethnicity Q1
Age of start menopause Q1
Smoking and alcohol use Q1, Q2, Q3
Use of dairy products Q1, Q2, Q3
Use of vitamin D/ calcium/ multi-vitamin supplements Q1, Q2, Q3
Medication use Q1, Q2, Q3
Use of osteoporosis medication Q1, Q2, Q3
Prednison use Q1
Chronic diseases Q1, Q2, Q3
Quality of life (EuroQoL-5D) Q2, Q3
Consultation physician Q2, Q3
Hospital admission Q2, Q3
Dizziness Q2
Incontinence Q2
Memory complaints Q2
Depression and anxiety (PHQ-4) Q2
Attitude toward osteoporosis and perceived risks Q2
Adherence and persistence to use osteoporosis medication (ADEOS-12) Q2a
Side effects of osteoporosis medication Q2a
Independence Q3
Diabetes treatment Q3b
Diabetes complications and hypoglycaemic attacks Q3b
Sunlight exposure QDc
Vitamin D via diet and supplements QDc
  1. Q1 baseline questionnaire, Q2 questionnaire after 18 months, Q3 questionnaire after 36 months, QD = vitamin D questionnaire. aThese items are questioned only to patients with an indication for treatment. bThese items are questioned only to patients with diabetes mellitus. cThis questionnaire has been send to a random sample of the first participants